Masteron 100 mg is an injectable anabolic androgenic steroid containing drostanolone propionate, known for its moderate anabolic and strong androgenic properties. It is primarily recognized for promoting lean muscle mass, enhancing muscle hardness, aRead More
Active Compound:
Drostanolone Propionate
Strength:
100 Mg
Drug Category:
Anabolic Androgenic Steroid
Administration Mode:
Intramuscular Injection
Masteron 100 mg is an injectable anabolic androgenic steroid containing drostanolone propionate, known for its moderate anabolic and strong androgenic properties. It is primarily recognized for promoting lean muscle mass, enhancing muscle hardness, and supporting strength gains while minimizing water retention when used under controlled, medically supervised conditions. The formulation is a short-acting ester, allowing for rapid absorption and consistent blood levels after intramuscular injection. Due to its potent hormonal effects, Masteron is classified as a prescription-only and controlled substance, intended strictly for authorized medical or veterinary use.
| Active Compound | Drostanolone Propionate |
| Strength | 100 mg |
| Drug Category | Anabolic androgenic steroid |
| Administration Mode | Intramuscular injection |
| Steroid Type | Propionate ester |
| Action Type | Androgen receptor stimulation |
| Pharmacological Effect | Increases muscle hardness |
| Primary Medical Use | Previously breast cancer therapy |
| Body Metabolism | Liver metabolism |
| Elimination Route | Renal excretion |
| Half-Life | Approx. 48 hours |
| Protein Binding | High plasma binding |
| Aromatization | Non-aromatizing |
| Water Retention Risk | Minimal |
| Injection Frequency | Every 2–3 days |
| Drug Class Code | ATC A14 |
| Chemical Group | Androstane steroid |
| Formulation Base | Oil suspension |
| Packaging | Multi-dose vial |
| Active Compound | Drostanolone Propionate |
| Strength | 100 mg |
| Drug Category | Anabolic androgenic steroid |
| Administration Mode | Intramuscular injection |
| Steroid Type | Propionate ester |
| Action Type | Androgen receptor stimulation |
| Pharmacological Effect | Increases muscle hardness |
| Primary Medical Use | Previously breast cancer therapy |
| Body Metabolism | Liver metabolism |
| Elimination Route | Renal excretion |
| Half-Life | Approx. 48 hours |
| Protein Binding | High plasma binding |
| Aromatization | Non-aromatizing |
| Water Retention Risk | Minimal |
| Injection Frequency | Every 2–3 days |
| Drug Class Code | ATC A14 |
| Chemical Group | Androstane steroid |
| Formulation Base | Oil suspension |
| Packaging | Multi-dose vial |
3316 E Richert AveFresno, CA 93726, USA
GET DIRECTION